chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received incorrect dose of Covid 19 vaccine. She should had received the vaccine for 5-11 years old. Instead she received the dose for 12 and older. No side effects have been reported as of today.
Information has been received from a Licensed Practical Nurse referring to a patient of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On 05-AUG-2015 the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 (0.5 ml, lot # L002310, expiration date 08-JUL-2016) intramuscularly. Concomitant drug was not reported. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
severe pain in left arm; This case was reported by a pharmacist via sales rep and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. The patient was treated with non-drug therapy (Ice Pack (No Medication)), paracetamol (Acetaminophen) and non-drug therapy (Acupuncture). On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and experienced severe pain in left arm. The reporter mentioned that, patient sought to outpatient medical care and was treated with ice, acetaminophen and acupuncture. The reporter also mentioned that, pain resolved in several days with no further complications. The reporter consented to follow up.
A report was received from a health care professional on 11/18/03, concerning a 3 year old vaccinee of unknown gender who inadvertently received Fluvirin on 11/11/03. On 11/11/03 the vaccinee received 0.25ml Fluvirin. The vaccinee did not exhibit any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1/19/04: A follow up report was received from a health care professional indicating that the 3 year old female vaccinee received Fluvirin on 11/10/03 approximately. No follow up pending, all information received.
Information has been received from a registered nurse concerning a 5 year old female "HIV daycare attendee" who on 1/12/00 was vaccinated with varicella. On 1/25/00, the pt developed a vesicular rash on her abdomen. Unspecified medical attention was sought. Additional information has been requested.
Started itching around the site; Has turned red; Swollen around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Started itching around the site), VACCINATION SITE ERYTHEMA (Has turned red) and VACCINATION SITE SWELLING (Swollen around the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Sensitive skin. Concomitant products included LOSARTAN, METOPROLOL and HYDROCHLOROTHIAZIDE for Hypertension.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Started itching around the site), VACCINATION SITE ERYTHEMA (Has turned red) and VACCINATION SITE SWELLING (Swollen around the injection site). The patient was treated with BACITRACIN ZINC, POLYMYXIN B SULFATE (AQUAPHOR ANTIBIOTIC) for Itchy, at an unspecified dose and frequency. On 20-Feb-2021, VACCINATION SITE SWELLING (Swollen around the injection site) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Started itching around the site) outcome was unknown and VACCINATION SITE ERYTHEMA (Has turned red) was resolving. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow-up received as Telephone contact report , contains non-significant information. On 27-Apr-2021: Follow-up contains, Non-significant information.
This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a elderly male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced erythema of extremities. On an unknown date, the outcome of the erythema of extremities was unknown. It was unknown if the reporter considered the erythema of extremities to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter's father had a reaction to the SHINGRIX vaccine and his arm was red. The patient had denied permission to contact their physician.
Body aches, unable to function and do anything.  Chills and fever. Slight fever at 99.8. At times I feel so bad I want to go to the hospital.  Horrific headache, feels like my head will explode.
PATIENT COMPLAINS OF BRUISING AT INJECTION SITE, ERYTHEMA, WARMTH, BRUISING IN HEALING STAGES WHEN CLIENT RETURNED TO CLINIC ON 10/21/2010 FOR CLINIC STAFF TO EVALUATE.  NO ERYTHEMA, NO INDURATION, ECCHYMOSIS PRESENT.
Fast heart rate 99-101. Bp 147/76. Body pain, coldness. Dizziness. Oxygen level 94. Have taken my bp meds due to hypertension and still wont go down.
extreme dizziness; Fever; Chills; Fatigue; still dizzy upon standing or laying; This is a spontaneous report from a contactable consumer (patient). A 62-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 05Feb2021 12:00 (62-year-old at vaccination) as Dose number unknown, Single for COVID-19 immunization. The patient's Medical history included Haemochromatosis. No known allergies were reported. No concomitant medications received by the patient in two weeks after vaccination. Vaccination facility type was reported as Other. The patient had not received any other vaccine four weeks prior to vaccination. T The patient tested for covid prior vaccination. On 05Feb2021 at 15:00, the reporter stated that, his adverse event most have subsided, except extreme dizziness, had fever, chills, fatigue and dizziness, still dizzy upon standing or laying, very dizzy on day 5. These ae resulted in Doctor or other healthcare professional office/clinic visit. The patient not tested for covid post vaccination. No treatment received for the resulted events. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Area of red inflammation on left arm; Area of red inflammation on left arm; Little knot below the injection site on her arm; Left arm was sore; This is a spontaneous report from the contactable consumers (patient's husband and patient herself). An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9264), via an unspecified route of administration in left arm, on 26Feb2021 (at the age of 81 years), as dose 2, single, for COVID-19 immunization. The patient's medical history included serious diarrhea and chronic obstructive pulmonary disease (COPD) from probably 25 years ago (1996); both were ongoing. The patient's serious diarrhea was ongoing for a long time. The patient started with antibiotics about 1.5 years ago. The patient has fought serious diarrhea off and on and was getting medicine for it, but it has been a while since she had taken. The patient had like 3 antibiotics before being hospitalized where she had intravenous (IV) for 15 days in the hospital. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (Lot Number: EN6202) on 05Feb2021 (at the age of 81 years) for COVID-19 immunization (left arm). The patient got her second Pfizer COVID-19 vaccine injection on Friday the 26th and things seemed to be going well. On Saturday (27Feb2021) at unknown time in the morning, the patient got a red inflammation down from the injection site on her arm. There also seemed to be a little knot below the injection site on her arm which was still there. When the patient changed clothes, she noticed that her left arm was sore and had an area of red inflammation on left arm and a little knot not at the actual injection site, but around 1 inch or so below the injection site on the same arm that she was administered the vaccine injection. The red inflammation down from the injection site on her arm has decreased. They put some cortisone cream on it, and it seems like the area is not a rash. They looked at the thing they gave them, and that rash was supposed to go over the whole body which did not happen to her. The red inflammation down from the injection site on her arm is maybe a 4-inch area of red inflammation. It looked like it could have been an infection, but the patient's husband knew it is not an infection. The arm that she got the injection in is also fairly sore too to the touch. The patient was recovering from the events.  No follow-up attempts are possible. No further information is expected.
Feels like Bladder Infection; Nap for 4.5 hours; Diarrhea; Arm hurt; had Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Arm hurt), CHILLS (had Chills), CYSTITIS (Feels like Bladder Infection) and SLEEP DEFICIT (Nap for 4.5 hours) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Bladder infection. Concomitant products included CIPROFLOXACIN (CIPRO [CIPROFLOXACIN]) for Bladder infection.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Arm hurt), CHILLS (had Chills) and SLEEP DEFICIT (Nap for 4.5 hours). On 24-Mar-2021, the patient experienced CYSTITIS (Feels like Bladder Infection). On 03-Mar-2021, DIARRHOEA (Diarrhea), PAIN IN EXTREMITY (Arm hurt), CHILLS (had Chills) and SLEEP DEFICIT (Nap for 4.5 hours) had resolved. At the time of the report, CYSTITIS (Feels like Bladder Infection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
4/10 + erythematous skin lateral upper thighs, back lumbar area and right upper lateral arms. Began after bedtime. Mom used calamine lotion. Given Clarinex syrup to use as needed.
Patient presented with suicidal thoughts and statements - Adjustment disorder with depressed mood. Behavioral health admission. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Vesicular rash to face, trunk, upper arms and groin; itching. Erythema left arm 2" long, 1.5" wide, hot to touch, itching also. Diagnosed as slight case of varicella by NP.
migraine, severe muscle soreness at site, down to elbow and up to and including neck - possibly triggering  migraine, severe fatigue.
This case was reported by a physician and described the occurrence of swelling injection site in a 4-year-old male subject who was vaccinated with KINRIX (GlaxoSmithKline). Previous and/ or concurrent vaccination included pandemic vaccine H1N1 (non-GSK) ; non-GSK manufacturer; intranasal given on 26 October 2009. There were no concurrent medications. On 26 October 2009 at 16:00 the subject received unspecified dose of KINRIX. On 27 October 2009, 1 day after vaccination with KINRIX, the subject experienced swelling injection site, injection site redness, injection site pruritus and local delayed type hypersensitivity response. At the time of reporting the events were unresolved. The physician considered the events were probably related to vaccination with KINIRIX. The subject consulted a health care professional regarding the events. The reporting physician is the subject's father.
5x5 circular reddened, partially raised area left tricep. Patient c/o itching only. No fever.
Pain at site of injection (48 hours), feeling of malaise and fatigue beginning about 8 hours post injection (lasted about 6 hours), pain and burning in thumb and index finger of right hand (injection in right upper arm), enlarged lymph notes in right axilla (notes on annual MRI post breast cancer evaluation).
Began feeling super weak, major chills (pins and needles type chills like your skin is crawling), fever, nausea, dizziness, migraine.
Patient experienced persistant pain occuring a few days after flu shot was given. Went to her doctor and they told her it was form of tendinitis or bursitis. Stating that still hurting after 6 weeks and that after 9 weeks full mobility back.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 48-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 with paxlovid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Left arm soreness at site of injection. On 10/7/09 @ 6:00 am left arm injection site skin warm to touch with redness,and increasing swelling accompanied with Fever 102.9 'F and headache. Seek an urgent care services, DX: Cellulitis and prescribed with Clindamycin 300 mg 2x/day
Child complained of pain and itching yesterday. Noticed redness yesterday and has not changed - per dad. Left arm lateral aspect from deltoid to elbow reddened, swelling and warm to touch.
I have received two Moderna COVID 19 Vaccines and three Boosters. Last Booster 09/09/2022  10/10/2022: Experienced Severe Hearing Loss in my right ear with Tinnitis/Vertigo. 10/12/2022: Urgent Care Appointment. Diagnosis: fluid on inner ear given antihistamines. 10/17/2022: Apt. with my Primary Care Physician. Prescribed Methylprednisolone 4mg dose pack - 1wk. 10/24-11/29/2022: No change. Received referral to ENT,. 11/09/2022: Apt. with ENT. Received ear examination and hearing test. Prognosis: Sudden Hearing Loss Right Ear/Tinnitis. Prognosis not good. Prescribed 2 week predisone therapy and scheduled brain MRI. 11/23/2022: Received Brain MRI.  Results: Severe damage to right ear cochlea. 11/29/2022: Followup apt with ENT. Received additional hearing teast with no improvement. 02/03/2023:  Apt with ENT Physician. Reviewed MRI. Advised I had severe sudden hearing loss with tinnitis. Reviewed MRI, advised I had severe damage to my right ear cochlea. Only options: Cochlea implant surgery or Bi-Cross/Cross hearing aides. 04/28/2023: Apt with Audiologist. Consultation reference possible effective hearing aides to assist in my hearing loss. Recommended Bi-Cross/Cross hearing aides. Currently reviewing possible solutions.
Area around vaccination site is swollen, red, and has a hives like appearance with radiated runners that look like welts. Area is warm to the touch and sore. Armpit of same arm is swollen and tender to the touch.
Moderna vaccine was still in the fridge and expired-5 doses had been given; Moderna vaccine was still in the fridge and expired-5 doses had been given; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was still in the fridge and expired-5 doses had been given) and PRODUCT STORAGE ERROR (Moderna vaccine was still in the fridge and expired-5 doses had been given) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 19-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was still in the fridge and expired-5 doses had been given). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna vaccine was still in the fridge and expired-5 doses had been given). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was still in the fridge and expired-5 doses had been given) and PRODUCT STORAGE ERROR (Moderna vaccine was still in the fridge and expired-5 doses had been given) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  On 16 Dec 2021 Moderna vaccine was pulled from the freezer. Beyond use date (BUD) of 15 Jan 2022 printed in red and taped to the top of the boxes. On 26 Jan 2022, it was still in the fridge and expired - 5 doses had been given at that point.  Treatment information was not provided.
G47.33 OBSTRUCTIVE SLEEP APNEA 4/6/2023 DM 2 W HYPERGLYCEMIA
On 11/14/19 @ 8.30 am (while in school) patient developed a migraine like headache & nausea and vomiting- No fever/SOB or rash- his Mother took him home, he slept and rested for the rest of the day. They did not seek medical attention.Mother called me to report this. I advised her to monitor patient and if symptoms did not improve or worsened to seek medical attention. I informed patient's Mother that I would complete a VAERS report, and explained what it was. 11/15/19  T/C to patient's mother, patient is improving, tummy still a little upset and he remained home from school today. No medical attention needed.
Patient is a 78 yo male w hx of a fib, cva, htn, and covid-19 mRNA injections. He was weak and could not get up. Per daughter the weakness was generalized and not focal. Pt was admitted for bilateral pna and metabolic encephalopathHe was on high oxygen amount. Pt was treated w iv anbx and breathing rx and iv steroid. He was fully injected with covid-19 mRNA shots. His lungs showed diffuse interstitial pneumonitis. It was also likely due to autoimmune pneumonitis induced by covid-19 mRNA shots. He suddently went into cardiac arrest and expired despite resuscitation.
Patient had soreness and red area under where the immunization was given to him 2 days after being given the vaccine. This was his 2nd dose from us for the SHINGRIX vaccine and he did not have a problem the first time he was given the immunization.
This spontaneous report was received from a receptionist refers to a unspecified number of patients of unknown age and gender. On unspecified dates since 27-DEC-2013, an unknown number of patients were vaccinated with GARDASIL (lot#, expiry not reported) after exposure to temperature outside prescribing information. No adverse events were reported. This is one of 3 reports received from the same reporter. Additional information has been requested.
Pt recvd vax & day p/vax exp dizziness & body aches were reported; c/o malaise;
Patient received 2nd Covid vaccine on 2/19/2021, shortly after patient states she did not feel well, like she was going to faint. Patient became pale, diaphoretic, pupils dilated and was unresponsive. I stayed with patient and supported her head/airway as she was seated in a chair. Dr. arrived, ED staff arrived and stretcher arrived, patient started to wake up and we assisted her to sit on the stretcher. Patient was alert , talkative and her color was better.  She had a small emesis x2. Patient then laid down on the stretcher and stated she was feeling better. Patient was taken to the ED via stretcher, she was alert and responsive.
Cried high pitch cry from 6 pm-2 am, not a whiney baby by history.  Went to emergency room but was never seen.
This spontaneous report as received from a register nurse concerning two patients of unknown age and gender who on 28-MAR-2014 were vaccinated with MMR II lot # 0649AE, 0.5 ml, subcutaneous that had expired on 27-MAR-2014. No adverse events were reported. Additional information has been requested.
Patient presented to the pharmacy on 1/19/19 at 1:40pm and stated she was "paralyzed" the day after the vaccine. She did not seek medical treatment due to her "high deductible". She stated she did notify her neurologist but not disclose of the date.
Child noted with hives on stomach Wed 7:00 pm (7/23/08), then hives appeared all over body 7/24/08 11:00 pm. Eyelids and face swollen. Face discolored red, itching. Child taken to hospital Thurs pm 7/24/08. Tx with Prednisone liquid. Mom given Rx for Prednisone and zantac. States was told to cont benadryl 25 mg PRN as already started per Mom on Thurs 7/24/08/.
approx 20min p/vax pt c/o moderate itching, swelling & warmth @ inj site;exam show  approx 2cm diameter red raised area, warm tot ouch;moderate itching;DPH given;ice pack to site itching resolving;redness dec;
Patient erroneously received expired Pfizer dose on 12/1/2021. Staff contacted Pfizer to inquire if this lot/batch was still viable at the time of vaccination. Following discussion with Pfizer, patient did not need to be revaccinated as stability data supported this excursion for 1 day post expiry from manufacturing data.
PATIENT RECEIVED VACCINE THAT EXPERIENCED A TEMPERATURE EXCURSION, VACCINE WAS KEPT IN THE REFRIGERATOR FOR MORE THAN 30 DAYS. ARM HURT.
Fever, chills, headache, sore arm, sore throat, body aches and nausea.
Looks like cellulitis; Red; Knot on her arm; hard to the touch; Sore arm; Slight swelling of the injection site; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE CELLULITIS (Looks like cellulitis) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE CELLULITIS (Looks like cellulitis). The patient was treated with AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AMOXICILLIN & CLAV. POTASSIUM) ongoing since an unknown date at a dose of 875-125 milligram. At the time of the report, VACCINATION SITE CELLULITIS (Looks like cellulitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Localized redness developed within 1 hour of the VARIVAX injection on her left arm. It grew to be 20 cm x 27 cm assoc with fever - BACTRIM 800/160 is helping. Fever gone over last 12 hrs. Pt feeling better.
Patient developed abscess at smallpox innoculation site (Left Deltoid). Pt noticed warmth and swelling on above date, and visited local ER on 5Aug12 for treatment, then again on 6Aug12 for followup. Pt was diagnosed with a general Abscess by ER, and prescribed antibiotics. Lesion was NOT drained, in part due to the smallpox innoculation that had been recieved. Pt then followed up with local military clinic, where he was observed to be improving.